Qu Biologics

    OverviewSuggest Edit

    Qu Biologics is a company that develops immunotherapies designed to restore normal immune function. It develops drugs for ulcerative colitis, Crohn's disease, arthritis, lung cancer, autoimmune diseases, autoimmune disorders, and inflammatory bowel disease.
    TypePrivate
    Founded2007
    HQBurnaby, CA
    Websitequbiologics.com
    Overall CultureC

    Latest Updates

    Employees (est.) (Nov 2021)48(-2%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Qu Biologics

    Hal Gunn

    Hal Gunn

    CEO & Co-Founder, Director
    Simon Sutcliffe

    Simon Sutcliffe

    Chief Medical Officer
    Alun Rees

    Alun Rees

    Vice President
    Mike Leschuk

    Mike Leschuk

    Director
    Shirin Kalyan

    Shirin Kalyan

    Vice President, Scientific Innovation
    Show more

    Qu Biologics Office Locations

    Qu Biologics has an office in Burnaby
    Burnaby, CA (HQ)
    4475 Wayburne Dr #305
    Show all (1)

    Qu Biologics Financials and Metrics

    Summary Metrics

    Founding Date

    2007

    Qu Biologics latest funding size

    $4 m
    Show all financial metrics

    Qu Biologics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    95/100

    SecurityScorecard logo

    Qu Biologics Online and Social Media Presence

    Embed Graph

    Qu Biologics Company Culture

    • Overall Culture

      C

      72/100

    • CEO Rating

      D-

      60/100

    • Compensation

      D+

      60/100

    Learn more on Comparably

    Qu Biologics News and Updates

    Qu Biologics Receives Additional Funding to Accelerate Clinical Development of Qu’s First-in-Class Immunotherapeutic for COVID-19 Prevention and Treatment

    VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce it is receiv…

    Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis

    VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, recently expanded its patent portfol…

    Qu Biologics Completes $8M Financing

    VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a private clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce an oversubsc…

    Qu Biologics Frequently Asked Questions

    • When was Qu Biologics founded?

      Qu Biologics was founded in 2007.

    • Who are Qu Biologics key executives?

      Qu Biologics's key executives are Hal Gunn, Simon Sutcliffe and Alun Rees.

    • How many employees does Qu Biologics have?

      Qu Biologics has 48 employees.

    • Who are Qu Biologics competitors?

      Competitors of Qu Biologics include Genprex, Vyripharm Biopharmaceuticals and SimSon Pharma.

    • Where is Qu Biologics headquarters?

      Qu Biologics headquarters is located at 4475 Wayburne Dr #305, Burnaby.

    • Where are Qu Biologics offices?

      Qu Biologics has an office in Burnaby.

    • How many offices does Qu Biologics have?

      Qu Biologics has 1 office.